AurKa Pharma
Montréal
About AurKa Pharma
AurKa Pharma is a special purpose company created to develop one compound to proof-of-concept. To date, the biopharmaceutical asset has completed GLP toxicology studies.it plans to begin clinical development in Q3-2017. Once cleared for clinical development by regulatory authorities, the it compound will be tested directly alone in solid tumors. Later on, the compound may be tested in one of a number of additional cancer indications with the goal of providing a clinical proof-of-concept of efficacy for cancer patients.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Funding stage: M&A
- Last round: Series Unknown (Sep 2016)
- Website: aurkapharma.com
Industries & Categories
Biotechnology, Medical, Medical Device, Pharmaceutical
Canonical: https://fsome.com/organization/aurka-pharma-3222088 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.